Jacob Torres - Publications

Affiliations: 
2011-2017 Department of Molecular, Cellular & Developmental Biology University of California, Santa Barbara, Santa Barbara, CA, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Torres JA, Holznecht N, Asplund DA, Amarlkhagva T, Kroes B, Rebello J, Agrawal S, Weimbs T. A Combination of ß-Hydroxybutyrate and Citrate Ameliorates Disease Progression in a Rat Model of Polycystic Kidney Disease. American Journal of Physiology. Renal Physiology. PMID 38095025 DOI: 10.1152/ajprenal.00205.2023  0.705
2023 Cukoski S, Lindemann CH, Arjune S, Todorova P, Brecht T, Kühn A, Oehm S, Strubl S, Becker I, Kämmerer U, Torres JA, Meyer F, Schömig T, Hokamp NG, Siedek F, et al. Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial. Cell Reports. Medicine. 101283. PMID 37935200 DOI: 10.1016/j.xcrm.2023.101283  0.736
2022 Tonum K, Srimai N, Chabang N, Fongsupa S, Tuchinda P, Torres JA, Weimbs T, Soodvilai S. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease. International Journal of Molecular Sciences. 23. PMID 35457146 DOI: 10.3390/ijms23084328  0.754
2021 Strubl S, Oehm S, Torres JA, Grundmann F, Haratani J, Decker M, Vuong S, Kaur Bhandal A, Methot N, Haynie-Cion R, Meyer F, Siedek F, Korst U, Müller RU, Weimbs T. Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects. Clinical Kidney Journal. 15: 1079-1092. PMID 35664270 DOI: 10.1093/ckj/sfab162  0.746
2020 Strubl S, Torres JA, Spindt AK, Pellegrini H, Liebau MC, Weimbs T. STAT signaling in polycystic kidney disease. Cellular Signalling. 72: 109639. PMID 32325185 DOI: 10.1016/J.Cellsig.2020.109639  0.62
2019 Torres JA, Kruger SL, Broderick C, Amarlkhagva T, Agrawal S, Dodam JR, Mrug M, Lyons LA, Weimbs T. Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease. Cell Metabolism. PMID 31631001 DOI: 10.1016/J.Cmet.2019.09.012  0.751
2019 Torres JA, Rezaei M, Broderick C, Lin L, Wang X, Hoppe B, Cowley BD, Savica V, Torres VE, Khan S, Holmes RP, Mrug M, Weimbs T. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. The Journal of Clinical Investigation. 130. PMID 31361604 DOI: 10.1172/Jci128503  0.701
2018 Weimbs T, Shillingford JM, Torres J, Kruger SL, Bourgeois BC. Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 11: i27-i38. PMID 30581563 DOI: 10.1093/Ckj/Sfy089  0.795
2018 Olsan EE, West JD, Torres JA, Doerr N, Weimbs T. Identification of Targets of Interleukin-13 and Signal Transducer and Activator of Transcription-6 (STAT6) Signaling in Polycystic Kidney Disease. American Journal of Physiology. Renal Physiology. PMID 29513071 DOI: 10.1152/Ajprenal.00346.2017  0.707
2017 Rezaei M, Torres J, Lin L, Broderick C, Cowley B, Torres V, Khan S, Weimbs T. To035Calcium Oxalate Crystals Promote Cytogenesis And Aggravate Polycystic Kidney Disease Nephrology Dialysis Transplantation. 32. DOI: 10.1093/Ndt/Gfx133.To035  0.718
Show low-probability matches.